![](https://news.unchealthcare.org/wp-content/uploads/sites/1159/2022/11/ewend-600x813.jpeg)
November 21, 2022
Ewend Leads UNC Hospitals Site for Successful National Glioblastoma Clinical Trial
A new glioblastoma treatment from Northwest Biotherapeutics improved outcomes for many patients in a phase 3 clinical study, according to a study published in JAMA Oncology. Matt Ewend, MD, in the UNC Department of Neurosurgery and at UNC Lineberger, led the trial site at the N.C. Basnight Cancer Hospital.